Résumé :
|
[BDSP. Notice produite par INIST-CNRS HSpR0x5W. Diffusion soumise à autorisation]. Objectives. In California, injection drug users (IDUs) comprise the second leading risk group for human immunodeficiency virus (HIV) infection and the majority of hepatitis C virus (HCV) cases. Innovative disease screening and prevention activities are needed to improve disease surveillance and to guide appropriate public health responses. This study tested the hypothesis that offering HIV counseling and testing (C & T) concurrently with HCV C & T will increase HIV C & T rates among IDUs. Methods. From February through June 2003, HIV and HCV C & T were integrated in five California local health jurisdictions. HIV C & T and disclosure rates among IDUs were monitored when HIV C & T was offered alone during a baseline phase and when offered with HCV C & T during an intervention phase. Results. Among IDUs, HIV C & T rates were significantly higher when HIV and HCV C & T were offered together (27.1%, 354/1,305) than when HIV C & T services were offered alone (8.4%, 138/1,645) (p
|